84 reports of this reaction
2.5% of all NITROUS OXIDE reports
#7 most reported adverse reaction
SUBACUTE COMBINED CORD DEGENERATION is the #7 most commonly reported adverse reaction for NITROUS OXIDE, manufactured by AGL Welding Supply Co., Inc.. There are 84 FDA adverse event reports linking NITROUS OXIDE to SUBACUTE COMBINED CORD DEGENERATION. This represents approximately 2.5% of all 3,365 adverse event reports for this drug.
Patients taking NITROUS OXIDE who experience subacute combined cord degeneration should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
SUBACUTE COMBINED CORD DEGENERATION is a less commonly reported adverse event for NITROUS OXIDE, but still significant enough to appear in the safety profile.
In addition to subacute combined cord degeneration, the following adverse reactions have been reported for NITROUS OXIDE:
SUBACUTE COMBINED CORD DEGENERATION has been reported as an adverse event in 84 FDA reports for NITROUS OXIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
SUBACUTE COMBINED CORD DEGENERATION accounts for approximately 2.5% of all adverse event reports for NITROUS OXIDE, making it a notable side effect.
If you experience subacute combined cord degeneration while taking NITROUS OXIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.